Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-07

Study Completion Date

2052-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Registry of Pancreatic Disease

NCT03807687

Pancreatic Diseases Pancreatic Neoplasms Pancreatitis

RECRUITING

Pancreas Registry and High Risk Registry

NCT02775461

Pancreas Cancer Pancreatitis Chronic Pancreatitis +3 more

RECRUITING

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

NCT05380414

Metastatic Pancreatic Cancer Advanced Pancreatic Cancer

RECRUITING NA

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

NCT06151223

Pancreatic Cancer Pancreatic Ductal Adenocarcinoma PDAC +1 more

RECRUITING

Prospective Monocentric Clinical-biological Database

NCT04136132

Pancreatic Cancer

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PDAC - Pancreatic Ductal Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Register

Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≤55 years old at the time of diagnosis of pancreatic cancer
* Age ≥ 18 years
* Written informed consent obtained.

Exclusion Criteria

* Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
* Absence of informed consent.
* Age \< 18 years or \> 55 years old at the time of diagnosis of pancreatic cancer

Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No